Aditxt, Inc. Common Stock (ADTX)

Price$0.35

Favorite Metrics

Price vs S&P 500 (26W)-108.67%

Price vs S&P 500 (4W)-76.09%

Market Capitalization$392,810

All Metrics

Book Value / Share (Quarterly)$3692.04

P/TBV (Annual)0.30x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)6.80%

Cash Flow / Share (Quarterly)$-3551.84

Price vs S&P 500 (YTD)-97.64%

Gross Margin (TTM)-1134.96%

Net Profit Margin (TTM)-709901.85%

EPS (TTM)$-26198.93

10-Day Avg Trading Volume2.57M

EPS Excl Extra (TTM)$-26198.93

EPS (Annual)$-3444649.00

ROI (Annual)-234.80%

Gross Margin (Annual)-368.30%

Net Profit Margin (5Y Avg)-9115.52%

Cash / Share (Quarterly)$25.64

Revenue Growth QoQ (YoY)-89.05%

ROA (Last FY)-107.16%

Revenue Growth TTM (YoY)-99.84%

EBITD / Share (TTM)$-18180.32

ROE (5Y Avg)-331.87%

Operating Margin (TTM)-345414.62%

Cash Flow / Share (Annual)$-119729.43

P/B Ratio0.03x

P/B Ratio (Quarterly)0.24x

Net Income / Employee (Annual)$-1

EV / Revenue (TTM)884.42x

Net Interest Coverage (TTM)-4.04x

ROA (TTM)-156.65%

EPS Incl Extra (Annual)$-3444649.00

Current Ratio (Annual)0.09x

Quick Ratio (Quarterly)0.02x

3-Month Avg Trading Volume0.53M

52-Week Price Return-99.98%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$3690.77

P/S Ratio (Annual)2.93x

Asset Turnover (Annual)0.00x

52-Week High$2594.48

Operating Margin (5Y Avg)-8682.65%

EPS Excl Extra (Annual)$-3444649.00

26-Week Price Return-99.92%

Quick Ratio (Annual)0.08x

13-Week Price Return-92.56%

Total Debt / Equity (Annual)0.65x

Current Ratio (Quarterly)0.02x

Enterprise Value$5.262

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)1.66x

Pretax Margin (Annual)-26136.32%

Cash / Share (Annual)$5950.21

3-Month Return Std Dev175.83%

Net Income / Employee (TTM)$-2

ROE (Last FY)-388.37%

Net Interest Coverage (Annual)-20.44x

EPS Basic Excl Extra (Annual)$-3444649.00

Receivables Turnover (TTM)0.03x

Total Debt / Equity (Quarterly)0.36x

EPS Incl Extra (TTM)$-26198.93

Receivables Turnover (Annual)0.59x

ROI (TTM)-153.02%

P/S Ratio (TTM)66.02x

Pretax Margin (5Y Avg)-9115.52%

Revenue / Share (Annual)$13399.00

Tangible BV / Share (Annual)$63310.50

Price vs S&P 500 (52W)-135.07%

Year-to-Date Return-93.50%

5-Day Price Return-7.56%

EPS Normalized (Annual)$-3444649.00

ROA (5Y Avg)-157.09%

Net Profit Margin (Annual)-25708.25%

Month-to-Date Return-55.63%

Cash Flow / Share (TTM)$-201.51

EBITD / Share (Annual)$-2745845.00

Operating Margin (Annual)-20951.09%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-265.61%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-26198.93

P/TBV (Quarterly)0.24x

P/B Ratio (Annual)0.30x

Inventory Turnover (TTM)1.54x

Pretax Margin (TTM)-724419.66%

Book Value / Share (Annual)$63354.14

Price vs S&P 500 (13W)-95.43%

Beta1.37x

Revenue / Share (TTM)$1.09

ROE (TTM)-233.10%

52-Week Low$0.39

Analyst Recommendations

Apr 2024

May 2024

Jun 2024

Jul 2024

4.00

2.17

4.00

Industry Peers — Pharmaceuticals(308)

Symbol	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
ADTXAditxt, Inc. Common Stock	66.02x	-99.84%	-1134.96%	—	$0.35
LLYEli Lilly & Co.	13.45x	44.70%	83.04%	27.59%	$919.90
JNJJohnson & Johnson	5.82x	7.87%	67.95%	14.90%	$230.69
ABBVABBVIE INC.	5.97x	8.57%	71.62%	-2.88%	$203.71
MRKMerck & Co., Inc.	4.51x	1.31%	78.55%	21.23%	$117.10
AZNAstraZeneca PLC	5.39x	8.63%	81.31%	21.88%	$200.69
NVSNovartis AG	4.87x	8.91%	75.82%	15.26%	$150.99
NVONovo-Nordisk A/S	3.74x	6.43%	80.98%	20.66%	$40.46
ABTAbbott Laboratories	3.71x	6.59%	56.50%	8.20%	$96.00
PFEPfizer Inc.	2.50x	-1.64%	75.81%	-3.51%	$27.52
BMYBristol-Myers Squibb Co.	2.52x	-0.22%	72.63%	—	$59.13

About

Aditxt Inc is a life sciences company developing immunomodulatory therapies focused on organ transplant tolerance and autoimmune disease treatment. Its pipeline includes Adimune, AditxtScore, and ADI-100, a novel Apoptotic DNA Immunotherapy designed to induce immune tolerance to transplanted organs by mimicking the body's natural tolerance mechanisms.